Comparison of Biomatrix and Orsiro Drug Eluting Stent
Condition(s):Coronary Artery Disease; Myocardial IschemiaLast Updated:September 25, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Coronary Artery Disease; Myocardial IschemiaLast Updated:September 25, 2019Completed
Condition(s):High Bleeding Risk; Coronary Artery Disease; Percutaneous Coronary InterventionLast Updated:March 4, 2022Recruiting
Condition(s):Peripheral Arterial DiseaseLast Updated:March 9, 2015Completed
Condition(s):Coronary Stent RestenosisLast Updated:June 30, 2022Recruiting
Condition(s):Drug-eluting Stent; Coronary Artery DiseaseLast Updated:November 1, 2023Recruiting
Condition(s):Patients; Sinusitis; Nasal PolypsLast Updated:June 18, 2021Unknown status
Condition(s):Atherosclerosis; IschemiaLast Updated:December 7, 2022Withdrawn
Condition(s):Coronary Heart Disease; Angioplasty, BalloonLast Updated:October 13, 2023Active, not recruiting
Condition(s):Coronary Artery DiseaseLast Updated:January 3, 2019Completed
Condition(s):Coronary ArteriosclerosisLast Updated:September 9, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.